Initial public offering of INIFY Laboratories on Euronext Growth, Oslo

Deal typeCapital Markets
Client nameINIFY Laboratories AB


BDO has provided financial due diligence in relation to INIFY Laboratories' listing on Euronext Growth.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within histopathology. Fully digital, standardised and AI- supported workflow is applied to optimise quality and response times, initially for prostate cancer.

The IPO date was 20 June 2022.

For futher information, please contact us.